Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 2,608,514 |
|
|||||
| News | - | ||||||
| Day High | 727.9915 | Low High |
|||||
| Day Low | 718.30 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eli Lilly and Co | LLY | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -5.55 | -0.76% | 726.65 | 19:51:38 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 724.48 | 718.30 | 727.9915 | 724.87 | 732.20 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 86,995 | 2,608,514 | $ 724.29 | $ 1,889,327,152 | - | 370.68 - 800.78 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:55 | 1 | $ 727.05 | USD |
Eli Lilly (LLY) Options Flow Summary
Eli Lilly and Co Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 688.75B | 950.16M | - | 34.12B | 5.24B | 5.52 | 131.43 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Eli Lilly News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LLY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 749.59 | 754.72 | 718.30 | 734.62 | 2,348,467 | -22.94 | -3.06% |
| 1 Month | 780.32 | 793.67 | 718.30 | 755.77 | 2,385,837 | -53.67 | -6.88% |
| 3 Months | 647.58 | 800.78 | 643.17 | 751.61 | 3,050,185 | 79.07 | 12.21% |
| 6 Months | 597.07 | 800.78 | 547.61 | 669.06 | 3,082,028 | 129.58 | 21.70% |
| 1 Year | 385.05 | 800.78 | 370.68 | 583.82 | 3,046,811 | 341.60 | 88.72% |
| 3 Years | 188.57 | 800.78 | 178.5779 | 387.10 | 2,993,108 | 538.08 | 285.35% |
| 5 Years | 117.75 | 800.78 | 101.36 | 274.61 | 3,333,694 | 608.90 | 517.11% |
Eli Lilly Description
| Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. |
